- Home
- DRS vs LEGN Comparison
DRS vs LEGN Comparison
Compare DRS & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRS
- LEGN
- Stock Information
- Founded
- DRS 1969
- LEGN 2014
- Country
- DRS United States
- LEGN United States
- Employees
- DRS N/A
- LEGN N/A
- Industry
- DRS Military/Government/Technical
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- DRS Industrials
- LEGN Health Care
- Exchange
- DRS Nasdaq
- LEGN Nasdaq
- Market Cap
- DRS 8.3B
- LEGN 7.0B
- IPO Year
- DRS N/A
- LEGN 2020
- Fundamental
- Price
- DRS $40.38
- LEGN $27.80
- Analyst Decision
- DRS Buy
- LEGN Strong Buy
- Analyst Count
- DRS 6
- LEGN 13
- Target Price
- DRS $38.33
- LEGN $75.67
- AVG Volume (30 Days)
- DRS 1.1M
- LEGN 1.6M
- Earning Date
- DRS 05-01-2025
- LEGN 05-13-2025
- Dividend Yield
- DRS 0.44%
- LEGN N/A
- EPS Growth
- DRS 25.90
- LEGN N/A
- EPS
- DRS 0.88
- LEGN N/A
- Revenue
- DRS $3,345,000,000.00
- LEGN $728,303,000.00
- Revenue This Year
- DRS $9.55
- LEGN $65.96
- Revenue Next Year
- DRS $6.15
- LEGN $52.55
- P/E Ratio
- DRS $46.22
- LEGN N/A
- Revenue Growth
- DRS 13.58
- LEGN 112.46
- 52 Week Low
- DRS $21.98
- LEGN $29.27
- 52 Week High
- DRS $42.62
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- DRS 62.51
- LEGN 29.31
- Support Level
- DRS $39.21
- LEGN $30.25
- Resistance Level
- DRS $43.20
- LEGN $33.30
- Average True Range (ATR)
- DRS 1.62
- LEGN 1.72
- MACD
- DRS -0.01
- LEGN -0.41
- Stochastic Oscillator
- DRS 61.94
- LEGN 3.14
About DRS Leonardo DRS Inc.
Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. The company is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.